Nutrition in Alzheimer’s disease: a review of an underappreciated pathophysiological mechanism

Jiang, Jiwei; Shi, Hanping; Jiang, Shirui; Wang, Anxin; Zou, Xinying; Wang, Yanli; Li, Wenyi; Zhang, Yuan; Sun, Mengfan; Xu, Jun

doi:10.1007/s11427-022-2276-6

Cited by 7 publications

(1 citation statement)

References 231 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This economic burden has prompted the ongoing exploration and development of drugs for the treatment of AD. The accumulation of extracellular β-amyloid (Aβ) and the hyperphosphorylation of intracellular Tau are classical pathological features of AD [2][3][4]. However, drugs developed that target Aβ or Tau alone are not satisfactory, suggesting Pharmaceutics 2023, 15, 1568 2 of 23 that a deeper understanding of the pathogenesis of AD should be explored to reveal more comprehensive approaches to delay or prevent the development of AD.…”

Section: Introductionmentioning

confidence: 99%

The Protective Effect of Mangiferin on Formaldehyde-Induced HT22 Cell Damage and Cognitive Impairment

et al. 2023

View full text Add to dashboard Cite

Formaldehyde (FA) has been found to induce major Alzheimer’s disease (AD)-like features including cognitive impairment, Aβ deposition, and Tau hyperphosphorylation, suggesting that it may play a significant role in the initiation and progression of AD. Therefore, elucidating the mechanism underlying FA-induced neurotoxicity is crucial for exploring more comprehensive approaches to delay or prevent the development of AD. Mangiferin (MGF) is a natural C-glucosyl-xanthone with promising neuroprotective effects, and is considered to have potential in the treatment of AD. The present study was designed to characterize the effects and mechanisms by which MGF protects against FA-induced neurotoxicity. The results in murine hippocampal cells (HT22) revealed that co-treatment with MGF significantly decreased FA-induced cytotoxicity and inhibited Tau hyperphosphorylation in a dose-dependent manner. It was further found that these protective effects were achieved by attenuating FA-induced endoplasmic reticulum stress (ERS), as indicated by the inhibition of the ERS markers, GRP78 and CHOP, and downstream Tau-associated kinases (GSK-3β and CaMKII) expression. In addition, MGF markedly inhibited FA-induced oxidative damage, including Ca2+ overload, ROS generation, and mitochondrial dysfunction, all of which are associated with ERS. Further studies showed that the intragastric administration of 40 mg/kg/day MGF for 6 weeks significantly improved spatial learning ability and long-term memory in C57/BL6 mice with FA-induced cognitive impairment by reducing Tau hyperphosphorylation and the expression of GRP78, GSK-3β, and CaMKII in the brains. Taken together, these findings provide the first evidence that MGF exerts a significant neuroprotective effect against FA-induced damage and ameliorates mice cognitive impairment, the possible underlying mechanisms of which are expected to provide a novel basis for the treatment of AD and diseases caused by FA pollution.

show abstract

Section: Introductionmentioning

confidence: 99%